232 related articles for article (PubMed ID: 30799654)
41. In situ Co-Delivery of Doxorubicin and Cisplatin by Injectable Thermosensitive Hydrogels for Enhanced Osteosarcoma Treatment.
Si M; Xia Y; Cong M; Wang D; Hou Y; Ma H
Int J Nanomedicine; 2022; 17():1309-1322. PubMed ID: 35345787
[TBL] [Abstract][Full Text] [Related]
42. Mixed Liposome Approach for Ratiometric and Sequential Delivery of Paclitaxel and Gemcitabine.
Liu Y; Tamam H; Yeo Y
AAPS PharmSciTech; 2018 Feb; 19(2):693-699. PubMed ID: 28971370
[TBL] [Abstract][Full Text] [Related]
43. A conductive gelatin methacrylamide hydrogel for synergistic therapy of osteosarcoma and potential bone regeneration.
Liu X; Zhang Y; Wu H; Tang J; Zhou J; Zhao J; Wang S
Int J Biol Macromol; 2023 Feb; 228():111-122. PubMed ID: 36563819
[TBL] [Abstract][Full Text] [Related]
44. pH-sensitive stearoyl-PEG-poly(methacryloyl sulfadimethoxine) decorated liposomes for the delivery of gemcitabine to cancer cells.
Bersani S; Vila-Caballer M; Brazzale C; Barattin M; Salmaso S
Eur J Pharm Biopharm; 2014 Nov; 88(3):670-82. PubMed ID: 25157908
[TBL] [Abstract][Full Text] [Related]
45. Higher Gemcitabine Dose Was Associated With Better Outcome of Osteosarcoma Patients Receiving Gemcitabine-Docetaxel Chemotherapy.
Lee JA; Jeon DG; Cho WH; Song WS; Yoon HS; Park HJ; Park BK; Choi HS; Ahn HS; Lee JW; Yoo KH; Sung KW; Koo HH; Kang HJ; Park KD; Shin HY; Koh KN; Im HJ; Seo JJ; Lim YJ; Baek HJ; Kook H
Pediatr Blood Cancer; 2016 Sep; 63(9):1552-6. PubMed ID: 27197055
[TBL] [Abstract][Full Text] [Related]
46. Fabrication of dopamine conjugated with protein @metal organic framework for targeted drug delivery: A biocompatible pH-Responsive nanocarrier for gemcitabine release on MCF‑7 human breast cancer cells.
Abd Al-Jabbar S; Atiroğlu V; Hameed RM; Guney Eskiler G; Atiroğlu A; Deveci Ozkan A; Özacar M
Bioorg Chem; 2022 Jan; 118():105467. PubMed ID: 34781115
[TBL] [Abstract][Full Text] [Related]
47. Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection.
Bastiancich C; Bianco J; Vanvarenberg K; Ucakar B; Joudiou N; Gallez B; Bastiat G; Lagarce F; Préat V; Danhier F
J Control Release; 2017 Oct; 264():45-54. PubMed ID: 28830791
[TBL] [Abstract][Full Text] [Related]
48. Precise engineering of hybrid molecules-loaded macromolecular nanoparticles shows
Liu D; Zhang W; Liu X; Qiu R
Drug Deliv; 2021 Dec; 28(1):776-786. PubMed ID: 33866910
[TBL] [Abstract][Full Text] [Related]
49. Antitumor activity of gemcitabine hydrochloride loaded lipid polymer hybrid nanoparticles (LPHNs): In vitro and in vivo.
Yalcin TE; Ilbasmis-Tamer S; Takka S
Int J Pharm; 2020 Apr; 580():119246. PubMed ID: 32205141
[TBL] [Abstract][Full Text] [Related]
50. Polymer Coated Iron Nanoparticles: Radiolabeling & In vitro Studies.
Yilmaz S; Ichedef C; Karatay KB; Teksöz S
Curr Radiopharm; 2021; 14(1):37-45. PubMed ID: 32351192
[TBL] [Abstract][Full Text] [Related]
51. Aerosol gemcitabine inhibits the growth of primary osteosarcoma and osteosarcoma lung metastases.
Koshkina NV; Kleinerman ES
Int J Cancer; 2005 Sep; 116(3):458-63. PubMed ID: 15800950
[TBL] [Abstract][Full Text] [Related]
52. Localized Controlled Delivery of Gemcitabine via Microsol Electrospun Fibers to Prevent Pancreatic Cancer Recurrence.
Xia G; Zhang H; Cheng R; Wang H; Song Z; Deng L; Huang X; Santos HA; Cui W
Adv Healthc Mater; 2018 Sep; 7(18):e1800593. PubMed ID: 30062854
[TBL] [Abstract][Full Text] [Related]
53. Tumor Microenvironment following Gemcitabine Treatment Favors Differentiation of Immunosuppressive Ly6C
Wu C; Tan X; Hu X; Zhou M; Yan J; Ding C
J Immunol; 2020 Jan; 204(1):212-223. PubMed ID: 31776206
[TBL] [Abstract][Full Text] [Related]
54. Lymph cancer chemotherapy: delivery of doxorubicin-gemcitabine prodrug and vincristine by nanostructured lipid carriers.
Ni S; Qiu L; Zhang G; Zhou H; Han Y
Int J Nanomedicine; 2017; 12():1565-1576. PubMed ID: 28280326
[TBL] [Abstract][Full Text] [Related]
55. Estrogen-functionalized liposomes grafted with glutathione-responsive sheddable chotooligosaccharides for the therapy of osteosarcoma.
Yin X; Feng S; Chi Y; Liu J; Sun K; Guo C; Wu Z
Drug Deliv; 2018 Nov; 25(1):900-908. PubMed ID: 29644882
[TBL] [Abstract][Full Text] [Related]
56. Gemcitabine-loaded DSPE-PEG-PheoA liposome as a photomediated immune modulator for cholangiocarcinoma treatment.
Kim DH; Im BN; Hwang HS; Na K
Biomaterials; 2018 Nov; 183():139-150. PubMed ID: 30170256
[TBL] [Abstract][Full Text] [Related]
57. Sustained delivery of gemcitabine
Xu L; Tang S; Yang H; Liang M; Ren P; Wei D; He J; Kong W; Liu P; Zhang T
J Mater Chem B; 2022 Aug; 10(33):6338-6350. PubMed ID: 35930367
[TBL] [Abstract][Full Text] [Related]
58. A hyaluronic acid conjugate engineered to synergistically and sequentially deliver gemcitabine and doxorubicin to treat triple negative breast cancer.
Vogus DR; Evans MA; Pusuluri A; Barajas A; Zhang M; Krishnan V; Nowak M; Menegatti S; Helgeson ME; Squires TM; Mitragotri S
J Control Release; 2017 Dec; 267():191-202. PubMed ID: 28823957
[TBL] [Abstract][Full Text] [Related]
59. Synergistic targeting/prodrug strategies for intravesical drug delivery--lectin-modified PLGA microparticles enhance cytotoxicity of stearoyl gemcitabine by contact-dependent transfer.
Neutsch L; Wirth EM; Spijker S; Pichl C; Kählig H; Gabor F; Wirth M
J Control Release; 2013 Jul; 169(1-2):62-72. PubMed ID: 23588390
[TBL] [Abstract][Full Text] [Related]
60. Paclitaxel and gemcitabine combinational drug-loaded mucoadhesive delivery system in the treatment of colon cancers.
Guo XY; Wang P; Du QG; Han S; Zhu SM; Lv YF; Liu GS; Hao ZM
Drug Res (Stuttg); 2015 Apr; 65(4):199-204. PubMed ID: 24941086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
